{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T14:46:14Z","timestamp":1772117174834,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,12,22]],"date-time":"2013-12-22T00:00:00Z","timestamp":1387670400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s00066-013-0474-3","type":"journal-article","created":{"date-parts":[[2013,12,20]],"date-time":"2013-12-20T09:05:07Z","timestamp":1387530307000},"page":"229-232","source":"Crossref","is-referenced-by-count":33,"title":["Unusual acute and delayed skin reactions during and after whole-brain radiotherapy in combination with the BRAF inhibitor vemurafenib","Ungew\u00f6hnliche akute und verz\u00f6gerte Hautreaktionen w\u00e4hrend und nach Ganzhirnbestrahlung in Kombination mit dem BRAF-Inhibitor Vemurafenib"],"prefix":"10.1007","volume":"190","author":[{"given":"B.","family":"Schulze","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Meissner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Wolter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"R\u00f6del","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,12,22]]},"reference":[{"key":"474_CR1","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/1097-0142(197808)42:2<660::AID-CNCR2820420237>3.0.CO;2-E","volume":"42","author":"Amer","year":"1978","unstructured":"Amer MH, Al-Sarraf M, Baker LH et al (1978) Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival. Cancer 42:660\u2013668","journal-title":"Cancer"},{"key":"474_CR2","doi-asserted-by":"crossref","unstructured":"Anker CJ, Ribas A, Grossmann AH et al (2013) Severe liver and skin toxicity after radiation and vemurafenib in metastatic melanoma. J Clin Oncol","DOI":"10.1200\/JCO.2012.44.7755"},{"key":"474_CR3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1479-5876-10-85","volume":"10","author":"Ascierto","year":"2012","unstructured":"Ascierto PA, Kirkwood JM, Grob JJ et al (2012) The role of BRAF V600 mutation in melanoma. J Transl Med 10:85","journal-title":"J Transl Med"},{"key":"474_CR4","doi-asserted-by":"crossref","unstructured":"Boussemart L, Boivin C, Claveau J et al (n d) Vemurafenib and Radiosensitization. JAMA Dermatol 2013:1\u20133","DOI":"10.1001\/jamadermatol.2013.4200"},{"key":"474_CR5","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/annonc\/mdt015","volume":"24","author":"Boussemart","year":"2013","unstructured":"Boussemart L, Routier E, Mateus C et al (2013) Prospective study of cutaneous side-effects associated with the BRAF inhibitor vemurafenib: a study of 42 patients. Ann Oncol 24:1691\u20131697","journal-title":"Ann Oncol"},{"key":"474_CR6","first-page":"6997","volume":"62","author":"Brose","year":"2002","unstructured":"Brose MS, Volpe P, Feldman M et al (2002) BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res 62:6997\u20137000","journal-title":"Cancer Res"},{"key":"474_CR7","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","volume":"364","author":"Chapman","year":"2011","unstructured":"Chapman PB, Hauschild A, Robert C et al (2011) Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 364:2507\u20132516","journal-title":"N Engl J Med"},{"key":"474_CR8","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"Davies","year":"2002","unstructured":"Davies H, Bignell GR, Cox C et al (2002) Mutations of the BRAF gene in human cancer. Nature 417:949\u2013954","journal-title":"Nature"},{"key":"474_CR9","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1056\/NEJMc1113752","volume":"366","author":"Dummer","year":"2012","unstructured":"Dummer R, Rinderknecht J, Goldinger SM (2012) Ultraviolet a and photosensitivity during vemurafenib therapy. N Engl J Med 366:480\u2013481","journal-title":"N Engl J Med"},{"key":"474_CR10","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s00066-013-0308-3","volume":"189","author":"Dziggel","year":"2013","unstructured":"Dziggel L, Segedin B, Podvrsnik NH et al (2013) Validation of a survival score for patients treated with whole-brain radiotherapy for brain metastases. Strahlenther Onkol 189:364\u2013366","journal-title":"Strahlenther Onkol"},{"key":"474_CR11","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1200\/JCO.2004.08.140","volume":"22","author":"Fife","year":"2004","unstructured":"Fife KM, Colman MH, Stevens GN et al (2004) Determinants of outcome in melanoma patients with cerebral metastases. J Clin Oncol 22:1293\u20131300","journal-title":"J Clin Oncol"},{"key":"474_CR12","first-page":"61","volume":"1835","author":"Fokas","year":"2013","unstructured":"Fokas E, Steinbach JP, Rodel C (2013) Biology of brain metastases and novel targeted therapies: time to translate the research. Biochim Biophys Acta 1835:61\u201375","journal-title":"Biochim Biophys Acta"},{"key":"474_CR13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s00066-011-0025-8","volume":"188","author":"Gani","year":"2012","unstructured":"Gani C, Muller AC, Eckert F et al (2012) Outcome after whole brain radiotherapy alone in intracranial leptomeningeal carcinomatosis from solid tumors. Strahlenther Onkol 188:148\u2013153","journal-title":"Strahlenther Onkol"},{"key":"474_CR14","doi-asserted-by":"crossref","unstructured":"Narayana A, Mathew M, Tam M et al (2013) Vemurafenib and radiation therapy in melanoma brain metastases. J Neurooncol","DOI":"10.1007\/s11060-013-1127-1"},{"key":"474_CR15","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1200\/JCO.2011.36.7680","volume":"30","author":"Oberholzer","year":"2012","unstructured":"Oberholzer PA, Kee D, Dziunycz P et al (2012) RAS mutations are associated with the development of cutaneous squamous cell tumors in patients treated with RAF inhibitors. J Clin Oncol 30:316\u2013321","journal-title":"J Clin Oncol"},{"key":"474_CR16","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1200\/EdBook_AM.2013.33.399","volume":"2013","author":"Ramakrishna","year":"2013","unstructured":"Ramakrishna N, Margolin KA (2013) Multidisciplinary approach to brain metastasis from melanoma; local therapies for central nervous system metastases. Am Soc Clin Oncol Educ Book 2013:399\u2013403","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"474_CR17","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1002\/1097-0142(19880501)61:9<1926::AID-CNCR2820610934>3.0.CO;2-I","volume":"61","author":"Retsas","year":"1988","unstructured":"Retsas S, Gershuny AR (1988) Central nervous system involvement in malignant melanoma. Cancer 61:1926\u20131934","journal-title":"Cancer"},{"key":"474_CR18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3171\/jns.1998.88.1.0011","volume":"88","author":"Sampson","year":"1998","unstructured":"Sampson JH, Carter JH Jr, Friedman AH et al (1998) Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg 88:11\u201320","journal-title":"J Neurosurg"},{"key":"474_CR19","doi-asserted-by":"crossref","first-page":"e220","DOI":"10.1200\/JCO.2012.44.4265","volume":"31","author":"Satzger","year":"2013","unstructured":"Satzger I, Degen A, Asper H et al (2013) Serious Skin Toxicity With the Combination of BRAF Inhibitors and Radiotherapy. J Clin Oncol 31:e220\u2013e222","journal-title":"J Clin Oncol"},{"key":"474_CR20","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/bjd.12010","volume":"167","author":"Sinha","year":"2012","unstructured":"Sinha R, Edmonds K, Newton-Bishop JA et al (2012) Cutaneous adverse events associated with vemurafenib in patients with metastatic melanoma: practical advice on diagnosis, prevention and management of the main treatment-related skin toxicities. Br J Dermatol 167:987\u2013994","journal-title":"Br J Dermatol"},{"key":"474_CR21","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/107327480901600307","volume":"16","author":"Sloan","year":"2009","unstructured":"Sloan AE, Nock CJ, Einstein DB (2009) Diagnosis and treatment of melanoma brain metastasis: a literature review. Cancer Control 16:248\u2013255","journal-title":"Cancer Control"},{"key":"474_CR22","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/sj.bjc.6605622","volume":"102","author":"Staudt","year":"2010","unstructured":"Staudt M, Lasithiotakis K, Leiter U et al (2010) Determinants of survival in patients with brain metastases from cutaneous melanoma. Br J Cancer 102:1213\u20131218","journal-title":"Br J Cancer"},{"key":"474_CR23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1056\/NEJMoa1105358","volume":"366","author":"Su","year":"2012","unstructured":"Su F, Viros A, Milagre C et al (2012) RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors. N Engl J Med 366:207\u2013215","journal-title":"N Engl J Med"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-013-0474-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-013-0474-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-013-0474-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T05:31:43Z","timestamp":1564983103000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-013-0474-3"}},"subtitle":["Two case reports","Zwei Fallberichte"],"short-title":[],"issued":{"date-parts":[[2013,12,22]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["474"],"URL":"https:\/\/doi.org\/10.1007\/s00066-013-0474-3","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,22]]}}}